Mural Oncology PLC (MURA)
(Delayed Data from NSDQ)
$3.23 USD
-0.07 (-2.12%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $3.23 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MURA 3.23 -0.07(-2.12%)
Will MURA be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for MURA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for MURA
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
Mural Oncology presents clinical data from Artistry-3 at ASCO
Seven new option listings on May 15th